Illinois
How Diamond v. Chakrabarty applies in Illinois: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patents).
Illinois adheres to the principles established in Diamond v. Chakrabarty, where the state allows for the patenting of genetically modified organisms. Courts in Illinois recognize the significance of utility and non-obviousness in patent applications as determined by federal law.
In Illinois, as per federal guidelines, living organisms that have been genetically engineered to exhibit new characteristics can be patented if they meet the criteria of novelty, utility, and non-obviousness.
The court ruled that a method for hedging risks in commodities trading was not patentable as it was an abstract idea.
The court held that a computer-implemented invention must exhibit something more than mere automation of a process to be patentable.
The Supreme Court ruled that certain diagnostic methods that only apply natural laws are not patentable, elaborating on the limits set by Chakrabarty.
Illinois law generally aligns with federal standards regarding patentability set forth in Diamond v. Chakrabarty. While the state enforces federal patent law, the state courts have also engaged in discussions pertaining to the scope of what constitutes a patentable invention under the confines of Illinois state law.
Understanding the implications of Diamond v. Chakrabarty is critical for the Illinois bar exam, especially in discussions concerning patent eligibility of biotechnological inventions.